Biliary Dilatation National Special Disease Cohort in China
Condition(s) studied
Study summary
This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data from the cohort to establish a Chinese cohort for bile duct dilatation. Based on this cohort, the study seeks to clarify the epidemiological characteristics, pathological features, standard classification, disease progression, cancer risk, and optimal timing for surgical intervention in patients with bile duct dilatation. Additionally, it will compare the perioperative risks, long-term outcomes, and quality of life among different types of patients (including Todani types I, IVa, and V) following surgical treatment, to establish standardized surgical treatment strategies for each type.
Eligibility
Primary outcome measure(s)
- Long-term complications rate — After 30 or 90 days of surgery
For patients who have undergone surgical treatment, the occurrences of long-term postoperative complications include recurrent cholangitis, pancreatitis, bile duct stones, liver failure, and other such conditions.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Beijing Tsinghua Chang Gung Hospital | Beijing | Beijing Municipality | Recruiting |
More Beijing Tsinghua Chang Gung Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06881004 on ClinicalTrials.gov ↗ ← All trials in China